| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arvinas, Inc. (ARVN) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. ARVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 202.5K | $2.06M | - | |
| CFO | 164.4K | $1.68M | - | |
| Other | 154.2K | $1.57M | - | |
| Dir | 76.0K | $774.7K | - | |
| Other | 31.7K | $323.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Berkowitz Noah | Chief Medical Officer | Sell | 6,435 | $11.10 | $71,431.07 | -3.1% | - | - | |
| Nov 7, 2025 | Loomis David K53 | Chief Accounting Officer | Sell | 230 | $9.89 | $2,274.70 | -0.7% | +21.9% | - | |
| Sep 22, 2025 | Morrison Briggs61 | Director | Buy | 30,000 | $7.57 | $227,010.00 | +65.2% | +63.6% | - | |
| Jun 24, 2025 | Saik Andrew | Chief Financial Officer | Sell | 5,700 | $7.61 | $43,377.00 | -3.4% | -2.7% | - | |
| Jun 17, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 2,583 | $7.49 | $19,346.67 | -1.6% | +3.5% | - | |
| Mar 18, 2025 | Berkowitz Noah | Chief Medical Officer | Sell | 8,658 | $8.59 | $74,372.22 | -7.3% | -12.5% | +29.3% | |
| Feb 24, 2025 | Loomis David K53 | Chief Accounting Officer | Sell | 1,214 | $16.75 | $20,334.50 | -6.0% | -60.1% | -26.0% | |
| Feb 24, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 4,207 | $16.70 | $70,238.05 | -2.1% | -60.1% | -26.0% | |
| Feb 24, 2025 | Taylor Ian74 | President, R&D | Sell | 9,020 | $16.71 | $150,752.20 | -2.7% | -60.1% | -26.0% | |
| Feb 24, 2025 | Houston John G79 | President And CEO | Sell | 31,338 | $16.72 | $523,880.70 | -1.3% | -60.1% | -26.0% |